SPGI S&P Global Inc. Loading... : Bullish and Bearish Analyst Opinions

Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
All Content
Source feeds
Buzzberg Top 50
All market capsNo capitalization filter
200 B and aboveMega
10 B to 200 BLarge
2 B to 10 BMid
0 to 2 BSmall
Custom
Enter market cap range in B USD
All directions
▲ Long
▼ Short
⛔ Avoid
✂ Close
◦ Others
Any score
LOW+
MED+
HIGH
? ?
16:15
Jul 12
Quality stocks unusually cheap now.
Many high-quality, world-class businesses with durable competitive advantages are currently trading at unusually attractive multiples (often below 20x earnings) due to short-term concerns. Examples include Microsoft (19x), Visa (21x), S&P Global (18x), Adobe (11x), Progressive (12x), Danaher, Johnson & Johnson, Thermo Fisher, McDonald's (21x), KKR, Union Pacific (20x), and Blackstone. This provides a rare long-term opportunity to buy quality at a discount.
SPGI 1ST
HIGH
01:19
Jul 08
Myles Author, Value Zoomer (Substack)
Buy SPGI — a short-biased picker built a 4% position and is considering adding, citing indiscriminate selling driven by mobility spinoff and intelligence segment concerns as a mispricing in a structurally moated ratings and indices franchise.
SPGI
MED
14:13
Jul 05
Author lists this ticker as part of their current portfolio and asks for critique; under current-position semantics this is a long/held position, though no fresh catalyst is stated.
SPGI
LOW
18:44
Jul 04
Author explicitly lists SPGI as a current portfolio holding in a monthly holdings update.
SPGI
LOW
18:40
Jul 04
Author holds S&P Global, viewing the June SaaS/data correction as a long-term entry; same institutional rotation headwind (long semis/short SaaS) seen as temporary and reversible.
SPGI
MED
13:24
Jul 02
Goldman cut price target on S&P Global to $490, reflecting negative analyst sentiment.
SPGI
MED
23:48
Jul 01
Myles Author, Value Zoomer (Substack)
Hold SPGI as the cheapest compounder in the basket; author maintains a 4% concentrated position based on relative valuation.
SPGI
MED
23:34
Jul 01
Myles Author, Value Zoomer (Substack)
Author notes a portfolio win from correlated short book gains but does not state a forward-looking position or explicit short thesis on any ticker.
SPGI
LOW
08:04
Jun 26
The tweet notes that SPGI's valuation is not as cheap as recent chatter suggests relative to its 20-year history, but the author does not state a position or forward call.
SPGI
12:03
Jun 20
Buy SPGI as a quality compounder trading at a 5-year valuation low despite revenue nearly doubling over that period — price/fundamental divergence creates a compelling entry while the market chases AI/semis.
SPGI 1ST
HIGH
03:59
Jun 17
TheValueist Founder, Atlas Peak Research
Watch these financial services beneficiaries of the GAI buildout; no author position disclosed, treat as research basket.
SPGI
MED
03:56
Jun 17
TheValueist Founder, Atlas Peak Research
Watch as beneficiaries of AI infrastructure financing. The author maps direct and fee-pool exposure across alternative managers, banks, boutiques, and ratings firms. No ownership stated.
SPGI
MED
15:52
Jun 11
Myles Author, Value Zoomer (Substack)
Author explicitly says SPGI is one of their two largest US longs, a current-position disclosure; no new action, but strict semantics make this long rather than watch.
SPGI
LOW
18:22
Jun 10
Author names SPGI as a current favorite in response to a direct question about top picks; no specific catalyst given beyond general conviction in the name at current levels.
SPGI
MED
00:04
Jun 04
Myles Author, Value Zoomer (Substack)
Author discloses SPGI as their largest current holding at 4% of portfolio, signaling high-conviction long exposure to S&P Global.
SPGI
MED
16:06
Jun 03
Myles Author, Value Zoomer (Substack)
Buy high-moat financial compounders (exchanges, payment networks, data/analytics) into recent weakness; speaker calculates attractive IRRs at current prices and is steadily adding, with CME, CBOE, and ICE specifically flagged for recent selloff-driven entry.
SPGI
MED
23:02
May 27
TheValueist Founder, Atlas Peak Research
Watch S&P Global as a low-to-medium positive beneficiary; its financial data and ratings datasets are differentiated, permissioned, and embedded in mission-critical workflows, supporting AI-driven monetization upside.
SPGI
MED
13:06
May 21
Myles Author, Value Zoomer (Substack)
Buy SPGI long-term because valuation at COVID-era lows offers a compelling risk/reward for passive portfolios.
SPGI
HIGH
23:25
May 19
Myles Author, Value Zoomer (Substack)
The author suggests S&P Global appears cheaper after breaking down its valuation, but the statement is hedged and lacks a clear forward-looking trade call.
SPGI
HIGH
15:22
May 19
Myles Author, Value Zoomer (Substack)
Buy SPGI due to attractive valuation and durable competitive advantages in ratings and indices businesses.
SPGI
HIGH
13:30
May 19
Buy SPGI for its strong duopoly with MCO and wide moat, mispriced in the SaaS selloff at historically low forward PE.
SPGI
MED
14:26
May 13
Myles Author, Value Zoomer (Substack)
The tweet questions the rationale behind S&P Global's 4% drop on Anthropic's legal AI release, suggesting the market reaction may be overblown.
SPGI
HIGH
21:19
May 09
u/Aggravating_Share761 Reddit r/ValueInvesting
Author states S&P Global looks “way too cheap” at around $1000; it’s a wide-moat financial data/index provider with recurring revenue. Market may be undervaluing SPGI’s stable cash flows and pricing power; a dip to $1000 offers a compelling entry for a long-term hold. Buy SPGI on dips to $1000 as a high-quality defensive growth compounder. Financial market slowdown could hit ratings/revenue; regulatory risk; interest rate sensitivity.
SPGI 1ST
HIGH
01:09
May 06
Myles Author, Value Zoomer (Substack)
Long a basket of data/payments giants that offer double-digit IRRs, wide moats, and have been unfairly sold off in the AI loser basket, while providing a natural hedge against shorts.
SPGI
HIGH
00:00
May 04
Bought 2,500 shares @ $431.39
Open market purchase: 2,500 shares at $431.39 ($1,078,475 total)
SPGI 1ST
HIGH
00:00
May 04
Bought 1,152 shares @ $434.03
Open market purchase: 1,152 shares at $434.03 ($500,003 total)
SPGI 1ST
HIGH
13:24
Mar 31
Myles Value investing zoomer, physics grad
The author is seeking to accumulate high-quality, resilient stocks to hedge against AI disruption and economic volatility.
09:45
Mar 24
Rahm explicitly states they picked up Nvidia at a lower valuation, Meta for its free cash flow yield, and highlights Progressive and S&P Global as high-quality, growing businesses. These companies are cheap, economically resilient, with strong fundamentals (e.g., 5-8% free cash flow yield, double-digit revenue growth), making them attractive investments during market uncertainty. LONG because they offer value and stability in a volatile environment, poised for long-term growth. A severe economic downturn or inflation spike could impair even quality businesses.
SPGI
14:00
Feb 25
Michael Batnick Managing Partner, Ritholtz Wealth Management The Compound News
Software stocks recently experienced their worst month since October 2008. Specific names like Salesforce (CRM) and ServiceNow (NOW) are down significantly, and Microsoft (MSFT) is down ~30% from highs. The market is panic-selling on the "AI Doom" thesis (AI replaces software seats/white-collar demand). Batnick believes this is an emotional overreaction ("The market is more drunk than sober"). If AI is as powerful as predicted, these tech incumbents will likely be the beneficiaries, not the victims. Aggressive buy on the dip. Batnick explicitly states, "I am going to buy Microsoft today. I am running into the fire." The "AI deflationary bust" thesis proves true, leading to structural decline in SaaS pricing power.
SPGI
20:16
Feb 22
Buy SPGI as a high‑quality company down 52% from ATH with a forward P/E of 21, reflecting discounted valuation.
SPGI 1ST
MED

About SPGI Analyst Coverage

Buzzberg tracks SPGI (S&P Global Inc.) across 17 sources. 27 bullish vs 0 bearish calls from 19 analysts. Sentiment: predominantly bullish (69%). 39 total trade ideas tracked. Latest voices: Alejandro Estebaranz, Myles, tacticzh.